Intralesional Vitamin D Injection for Treatment of Common Warts (NCT04278573) | Clinical Trial Compass
CompletedPhase 2
Intralesional Vitamin D Injection for Treatment of Common Warts
United States77 participantsStarted 2020-10-20
Plain-language summary
Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients seen at the Mayo Clinic Rochester practices
* Patients suffering from one or more cutaneous warts as diagnosed by the examining physician at baseline visit on typical diagnostic characteristics
* Able to provide consent
* Both recalcitrant and non-recalcitrant warts will be included
Exclusion Criteria:
* Patients with prior use of home or office-based destructive treatments for this wart(s) in the last 1 month with salicylic acid (SA) or cryotherapy
* Immunoadjuvant therapy for warts in the last 4 months (e.g Candida)
* History of vitamin D injection of warts ever
* High-dose vitamin D supplementation (\>4,000 IU daily or equivalent) in the preceding 3 months
* Pregnancy or lactation
* Facial or genital warts
* Lesions not felt by the examining clinician to be a wart (e.g., corns or calluses)
* Immunosuppression (to include immunosuppressive medications or conditions as judged by the physician evaluating the patient at the baseline visit).
* Allergy to sesame oil